Humacyte Inc (HUMA)
7.05
+0.63
(+9.81%)
USD |
NASDAQ |
May 20, 16:00
7.05
0.00 (0.00%)
After-Hours: 19:16
Humacyte Cash and Short Term Investments (Quarterly): 115.50M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 115.50M |
| December 31, 2023 | 80.45M |
| September 30, 2023 | 99.99M |
| June 30, 2023 | 114.60M |
| March 31, 2023 | 131.68M |
| December 31, 2022 | 151.88M |
| Date | Value |
|---|---|
| September 30, 2022 | 171.73M |
| June 30, 2022 | 189.04M |
| March 31, 2022 | 206.22M |
| December 31, 2021 | 225.50M |
| September 30, 2021 | 240.45M |
| December 31, 2020 | 39.93M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
39.93M
Minimum
Dec 2020
240.45M
Maximum
Sep 2021
147.25M
Average
141.78M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Aquestive Therapeutics Inc | 95.20M |
| Adial Pharmaceuticals Inc | 2.827M |
| Gritstone Bio Inc | 46.30M |
| Precision BioSciences Inc | 137.77M |
| Puma Biotechnology Inc | 107.16M |